TY - JOUR
T1 - Zeolites for theranostic applications
AU - Yazdi, Mohsen Khodadadi
AU - Zarrintaj, Payam
AU - Hosseiniamoli, Hadi
AU - Mashhadzadeh, Amin Hamed
AU - Saeb, Mohammad Reza
AU - Ramsey, Joshua D.
AU - Ganjali, Mohammad Reza
AU - Mozafari, Masoud
PY - 2020
Y1 - 2020
N2 - Theranostic platforms bring about a revolution in disease management. During recent years, theranostic nanoparticles have been utilized for imaging and therapy simultaneously. Zeolites, because of their porous structure and tunable properties, which can be modified with various materials, can be used as a delivery agent. The porous structure of a zeolite enables it to be loaded and unloaded with various molecules such as therapeutic agents, photosensitizers, biological macromolecules, MRI contrast agents, radiopharmaceuticals, near-infrared (NIR) fluorophores, and microbubbles. Furthermore, theranostic zeolite nanocarriers can be further modified with targeting ligands, which is highly interesting for targeted cancer therapies.
AB - Theranostic platforms bring about a revolution in disease management. During recent years, theranostic nanoparticles have been utilized for imaging and therapy simultaneously. Zeolites, because of their porous structure and tunable properties, which can be modified with various materials, can be used as a delivery agent. The porous structure of a zeolite enables it to be loaded and unloaded with various molecules such as therapeutic agents, photosensitizers, biological macromolecules, MRI contrast agents, radiopharmaceuticals, near-infrared (NIR) fluorophores, and microbubbles. Furthermore, theranostic zeolite nanocarriers can be further modified with targeting ligands, which is highly interesting for targeted cancer therapies.
UR - https://hdl.handle.net/1959.7/uws:61336
U2 - 10.1039/d0tb00719f
DO - 10.1039/d0tb00719f
M3 - Article
SN - 2050-750X
VL - 8
SP - 5992
EP - 6012
JO - Journal of Materials Chemistry B
JF - Journal of Materials Chemistry B
IS - 28
ER -
